News

Horizant ER 600mg Returning to Shelves

Shipments of Horizant ER tablets have commenced, and are expected to be available to patients in the first week of June.

WHO: No Yellow Fever Vaccine Booster Needed

The WHO's expert advisory group on immunization has concluded that a single dose of the yellow fever vaccine is sufficient to confer lifelong immunity against yellow fever disease.

Twitter Reveals Popular Health Beliefs About Acne

Twitter can teach health care providers about popular health-related beliefs regarding acne.

Marijuana Use Tied to Lower Fasting Insulin Level

Marijuana use is associated with lower levels of fasting insulin and insulin resistance and with smaller waist circumference.

DSM-4 Task Force Chairman Advises Caution With DSM-5

The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), has introduced several high-prevalence diagnoses at the boundary of normality which is likely to lead to considerable false-positive rates and unnecessary treatment.

iPhone App Can Transmit Heart Images Quickly

An iPhone app can transmit diagnostic electrocardiogram images accurately, quickly, and more reliably than e-mail.

Variation Found in Outpatient Cardiac Risk Factor Management

For practices enrolled in the Guideline Advantage program that aims to reduce risks for chronic disease, there is considerable variation in hypertension and hyperlipidemia control and in tobacco screening.

Risk Factors ID'd for Cutaneous Cell Carcinoma

The risks of metastasis and death associated with cutaneous squamous cell carcinoma are low, but significant, and risk factors for poor outcome include tumor diameter, invasion beyond fat, poor differentiation, and location.

Study: Midlife Fitness May Protect Against Cancer

Men's middle-aged fitness level may protect against cancer.

Combo Antibody Therapy Effective for Melanoma

Concurrent use of two immune checkpoint antibodies -- ipilimumab and nivolumab -- may be effective for the treatment of advanced melanoma.